ZA914158B - Pharmacologically active CNS compounds. - Google Patents
Pharmacologically active CNS compounds.Info
- Publication number
- ZA914158B ZA914158B ZA914158A ZA914158A ZA914158B ZA 914158 B ZA914158 B ZA 914158B ZA 914158 A ZA914158 A ZA 914158A ZA 914158 A ZA914158 A ZA 914158A ZA 914158 B ZA914158 B ZA 914158B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmacologically active
- active cns
- cns compounds
- compounds
- pharmacologically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909012312A GB9012312D0 (en) | 1990-06-01 | 1990-06-01 | Pharmacologically active cns compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA914158B true ZA914158B (en) | 1993-03-01 |
Family
ID=10676960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA914158A ZA914158B (en) | 1990-06-01 | 1991-05-30 | Pharmacologically active CNS compounds. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0459829A1 (fi) |
JP (1) | JPH0625193A (fi) |
AU (1) | AU630811B2 (fi) |
CA (1) | CA2043642A1 (fi) |
FI (1) | FI912622A (fi) |
GB (1) | GB9012312D0 (fi) |
HU (1) | HUT60726A (fi) |
IE (1) | IE911860A1 (fi) |
NZ (1) | NZ238358A (fi) |
PT (1) | PT97828B (fi) |
ZA (1) | ZA914158B (fi) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9203483D0 (en) * | 1992-02-19 | 1992-04-08 | Wellcome Found | Anti-inflammatory compounds |
CA2137782A1 (en) * | 1992-06-12 | 1993-12-23 | Meire Nakamura-Craig | Therapeutic triazine compounds and use |
FR2699077B1 (fr) * | 1992-12-16 | 1995-01-13 | Rhone Poulenc Rorer Sa | Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes. |
GB9306639D0 (en) * | 1993-03-30 | 1993-05-26 | Tocris Neuramin Limited | Organic compounds |
GB9625795D0 (en) * | 1996-12-12 | 1997-01-29 | Smithkline Beecham Plc | Novel treatment |
GB9726987D0 (en) | 1997-12-22 | 1998-02-18 | Glaxo Group Ltd | Compounds |
US6420354B1 (en) | 1998-06-08 | 2002-07-16 | Advanced Medicine, Inc. | Sodium channel drugs and uses |
US6479498B1 (en) | 1999-06-04 | 2002-11-12 | Theravance, Inc. | Sodium channel drugs and uses |
GB0613836D0 (en) | 2006-07-13 | 2006-08-23 | Univ Greenwich | New medical use of triazine derivatives |
GB0800741D0 (en) * | 2008-01-16 | 2008-02-20 | Univ Greenwich | Cyclic triazo and diazo sodium channel blockers |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3637688A (en) * | 1970-01-09 | 1972-01-25 | American Home Prod | 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines |
GR68380B (fi) * | 1979-06-01 | 1981-12-28 | Wellcome Found | |
EP0021120B1 (en) * | 1979-06-01 | 1983-04-06 | The Wellcome Foundation Limited | 3,5-diamino-1,2,4-triazine derivatives, process for preparing such compounds and pharmaceutical compositions containing them |
GB8328757D0 (en) * | 1983-10-27 | 1983-11-30 | Wellcome Found | Chemical compounds |
GB8613183D0 (en) * | 1986-05-30 | 1986-07-02 | Wellcome Found | Triazine salt |
-
1990
- 1990-06-01 GB GB909012312A patent/GB9012312D0/en active Pending
-
1991
- 1991-05-30 ZA ZA914158A patent/ZA914158B/xx unknown
- 1991-05-31 JP JP3235335A patent/JPH0625193A/ja active Pending
- 1991-05-31 EP EP91304962A patent/EP0459829A1/en not_active Withdrawn
- 1991-05-31 AU AU78099/91A patent/AU630811B2/en not_active Ceased
- 1991-05-31 CA CA002043642A patent/CA2043642A1/en not_active Abandoned
- 1991-05-31 HU HU911827A patent/HUT60726A/hu unknown
- 1991-05-31 FI FI912622A patent/FI912622A/fi not_active Application Discontinuation
- 1991-05-31 NZ NZ238358A patent/NZ238358A/en unknown
- 1991-05-31 IE IE186091A patent/IE911860A1/en unknown
- 1991-05-31 PT PT97828A patent/PT97828B/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT97828B (pt) | 1998-10-30 |
AU630811B2 (en) | 1992-11-05 |
CA2043642A1 (en) | 1991-12-02 |
HUT60726A (en) | 1992-10-28 |
PT97828A (pt) | 1992-03-31 |
HU911827D0 (en) | 1991-12-30 |
IE911860A1 (en) | 1991-12-04 |
EP0459829A1 (en) | 1991-12-04 |
NZ238358A (en) | 1994-02-25 |
FI912622A0 (fi) | 1991-05-31 |
FI912622A (fi) | 1991-12-02 |
JPH0625193A (ja) | 1994-02-01 |
GB9012312D0 (en) | 1990-07-18 |
AU7809991A (en) | 1991-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
OA09148A (en) | Pharmacologically active CNS compounds. | |
ZA914166B (en) | Pharmacologically active cns compounds | |
GR3018318T3 (en) | Pharmaceutical agents. | |
ZA914158B (en) | Pharmacologically active CNS compounds. | |
ZA917666B (en) | Heterocyclic compounds. | |
ZA926012B (en) | Cns active tetrahydrobenzothienopyridines | |
GB8918893D0 (en) | Pharmacologically active cns compounds | |
GB9019593D0 (en) | Novel pharmacologically active compounds | |
GB9218797D0 (en) | Pharmacologically active compounds | |
HRP940540A2 (en) | Pharmacologically active cns compounds | |
GB9118955D0 (en) | Pharmacologically active compounds | |
GB9216170D0 (en) | Pharmacologically active compounds | |
GB9225498D0 (en) | Pharmacologically active compounds | |
GB9220543D0 (en) | Pharmacologically active compounds | |
GB9217426D0 (en) | Pharmacologically active compounds | |
GB9225497D0 (en) | Pharmacologically active compounds | |
GB9013906D0 (en) | Active compounds | |
GB9002459D0 (en) | Active compounds | |
PH31665A (en) | Pharmaceutical active cns compounds. | |
ZA928526B (en) | CNS active tetrahydrobenzothienopzridines | |
GB9310830D0 (en) | Pharmacologically active compounds | |
GB9316531D0 (en) | Pharmacologically active compounds | |
GB9312668D0 (en) | Pharmacologically active compounds | |
ZA919966B (en) | Novel hydantoin compounds. | |
ZA917367B (en) | Pharmacologically active compounds and use. |